StockNews.com Initiates Coverage on Cutera (NASDAQ:CUTR)

Investment analysts at StockNews.com initiated coverage on shares of Cutera (NASDAQ:CUTR) in a report released on Tuesday. The brokerage set a “sell” rating on the medical device company’s stock.

Cutera Stock Performance

Shares of Cutera stock opened at $0.04 on Tuesday. Cutera has a 52-week low of $0.09 and a 52-week high of $3.00. The stock has a market capitalization of $787,254.00, a price-to-earnings ratio of -0.01 and a beta of 1.36. The company has a fifty day moving average of $0.35 and a 200-day moving average of $0.48.

Institutional Investors Weigh In On Cutera

An institutional investor recently raised its position in Cutera stock. Geode Capital Management LLC increased its holdings in Cutera, Inc. (NASDAQ:CUTR) by 25.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 248,257 shares of the medical device company’s stock after purchasing an additional 50,046 shares during the period. Geode Capital Management LLC owned approximately 1.23% of Cutera worth $88,000 as of its most recent SEC filing. 90.70% of the stock is currently owned by institutional investors.

Cutera Company Profile

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.